Borosil Scientific Ltd

Borosil Scientific Ltd

₹ 145 5.48%
21 May - close price
About

Since 1962, Borosil is into finest quality scientific and laboratory glassware, which is used in Quality Control in pharmaceutical industries, Food and Soil testing, Microbiology, and Biotechnology.[1]

Key Points

Borosil Group[1]
The company is a part of Borosil group which is into glassware and laboratory products,
scientific & industrial glassware, consumer & kitchenware products, and solar glass products. Group comprises of:
1. Borosil Renewables Ltd
2. Borosil Ltd
3. Borosil Scientific Ltd

  • Market Cap 1,289 Cr.
  • Current Price 145
  • High / Low 230 / 107
  • Stock P/E 48.2
  • Book Value 45.5
  • Dividend Yield 0.00 %
  • ROCE 10.3 %
  • ROE 6.85 %
  • Face Value 1.00

Pros

  • Company is almost debt free.

Cons

  • Stock is trading at 3.19 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
87.54 91.97 99.68 115.71 104.20 102.61 101.45 129.48
81.82 82.50 87.53 97.44 94.37 87.16 91.44 112.91
Operating Profit 5.72 9.47 12.15 18.27 9.83 15.45 10.01 16.57
OPM % 6.53% 10.30% 12.19% 15.79% 9.43% 15.06% 9.87% 12.80%
1.11 1.44 1.06 1.48 2.16 1.95 1.86 2.59
Interest 0.76 0.73 0.54 0.67 0.40 0.36 0.35 0.44
Depreciation 3.65 3.85 4.50 4.45 4.57 4.63 4.58 4.70
Profit before tax 2.42 6.33 8.17 14.63 7.02 12.41 6.94 14.02
Tax % -35.54% 20.22% 30.48% 35.27% 28.49% 29.09% 38.33% 38.52%
3.29 5.05 5.69 9.46 5.03 8.80 4.28 8.62
EPS in Rs 0.65 1.05 0.57 0.99 0.48 0.97
Raw PDF
Upcoming result date: today

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
390 438
345 386
Operating Profit 45 53
OPM % 12% 12%
5 8
Interest 3 2
Depreciation 16 18
Profit before tax 32 40
Tax % 26% 34%
23 27
EPS in Rs 2.65 3.01
Dividend Payout % -0% -0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 12%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 14%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Equity Capital 9 9
Reserves 367 395
18 14
95 90
Total Liabilities 488 509
192 188
CWIP 1 1
Investments 0 105
295 215
Total Assets 488 509

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
30 120
-2 -115
-16 -3
Net Cash Flow 12 1

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Mar 2025
Debtor Days 57 59
Inventory Days 244 218
Days Payable 102 79
Cash Conversion Cycle 200 198
Working Capital Days 177 184
ROCE % 10%

Shareholding Pattern

Numbers in percentages

Jun 2024Sep 2024Dec 2024Mar 2025
67.92% 67.86% 67.84% 67.81%
0.38% 0.37% 0.27% 0.24%
0.15% 0.01% 0.02% 0.02%
31.54% 31.74% 31.88% 31.91%
No. of Shareholders 62,35461,20160,37358,894

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents